Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database)

MLA

Patrick Wilton, et al. “Serum Insulin-like Growth Factor I (IGF-I), IGF-Binding Proteins 2 and 3, and the Risk for Development of Malignancies in Adults with Growth Hormone (GH) Deficiency Treated with GH: Data from KIMS (Pfizer International Metabolic Database).” The Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 9, July 2010. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4d97a63f73607733267c0bd8a33dfb07&authtype=sso&custid=ns315887.

APA

Patrick Wilton, Anders F Mattsson, Rolf C. Gaillard, Maria Koltowska-Häggström, Michael B. Ranke, & Vera Popovic. (2010). Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database). The Journal of Clinical Endocrinology and Metabolism, 95(9).

Chicago

Patrick Wilton, Anders F Mattsson, Rolf C. Gaillard, Maria Koltowska-Häggström, Michael B. Ranke, and Vera Popovic. 2010. “Serum Insulin-like Growth Factor I (IGF-I), IGF-Binding Proteins 2 and 3, and the Risk for Development of Malignancies in Adults with Growth Hormone (GH) Deficiency Treated with GH: Data from KIMS (Pfizer International Metabolic Database).” The Journal of Clinical Endocrinology and Metabolism 95 (9). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4d97a63f73607733267c0bd8a33dfb07&authtype=sso&custid=ns315887.